Diabetes, hypertension, overweight and hyperlipidemia and 7-day case-fatality in first myocardial infarction

IJC Metabolic and Endocrine

Volumn 12, Issue , 2016, Pages 30-35

  Quintana, H K ^a   Janszky, I ^b   Gigante, B ^a,c   Druid, H ^a   Ahlbom, A ^a   Hallqvist, J ^d   de Faire, U ^a,e   Leander, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c DANDERYD HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

7 day fatality; Diabetes; Fatality; Hyperlipidemia; Hypertension; Myocardial infarction; Obesity; Overweight

Indexed keywords

EID: 84973369505     PISSN: 22147624     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcme.2016.05.009     Document Type: Article

References (37)

1. Koopman C., Bots M.L., van Oeffelen A.A., van Dis I., Verschuren W.M., Engelfriet P.M., et al. Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007. Int. J. Cardiol. 2013, 168(2):993-998.
2. The National Board of Health and Welfare Myocardial Infarctions in Sweden 1990-2013 Sweden: Statistics - Health and Medical Care Last accessed Oct 26, 2015. URL:. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19595/2014-11-13.pdf.
3. Dudas K., Lappas G., Stewart S., Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation 2011, 123(1):46-52.
4. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E., Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999, 353(9164):1547-1557.
5. Ahmed B., Davis H.T., Laskey W.K. In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000-2010. J. Am. Heart Assoc. 2014, 3(4).
6. Capewell S., Livingston B.M., MacIntyre K., Chalmers J.W., Boyd J., Finlayson A., et al. Trends in case-fatality in 117,718 patients admitted with acute myocardial infarction in Scotland. Eur. Heart J. 2000, 21(22):1833-1840.
7. Alvarez-Leon E.E., Elosua R., Zamora A., Aldasoro E., Galcera J., Vanaclocha H., et al. Hospital resources and myocardial infarction case fatality. The IBERICA study. Rev. Esp. Cardiol. 2004, 57(6):514-523.
8. Canto J.G., Kiefe C.I., Rogers W.J., Peterson E.D., Frederick P.D., French W.J., et al. Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction). Am. J. Cardiol. 2012, 110(9):1256-1261.
9. Chun B.Y., Dobson A.J., Heller R.F. The impact of diabetes on survival among patients with first myocardial infarction. Diabetes Care 1997, 20(5):704-708.
10. Miettinen H., Lehto S., Salomaa V., Mahonen M., Niemela M., Haffner S.M., et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998, 21(1):69-75.
11. Pedersen F., Butrymovich V., Kelbaek H., Wachtell K., Helqvist S., Kastrup J., et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J. Am. Coll. Cardiol. 2014, 64(20):2101-2108.
12. Reina A., Colmenero M., de Hoyos E.A., Aros F., Marti H., Claramonte R., et al. Gender differences in management and outcome of patients with acute myocardial infarction. Int. J. Cardiol. 2007, 116(3):389-395.
13. Njolstad I., Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark study. Arch. Intern. Med. 1998, 158(12):1326-1332.
14. Wannamethee G., Whincup P.H., Shaper A.G., Walker M., MacFarlane P.W. Factors determining case fatality in myocardial infarction "who dies in a heart attack"?. Br. Heart J. 1995, 74(3):324-331.
15. Grey C, Jackson R, Schmidt M, Ezzati M, Asaria P, Exeter DJ, et al. One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8). Eur. Heart J. 2015 Oct 29 (Epub ahead of print) http://dx.doi.org/10.1093/eurheartj/ehv524.
16. Engstrom G., Hedblad B., Janzon L., Lindgarde F. Fatality of acute coronary events in relation to hypertension and low-grade inflammation: a population-based cohort study. J. Hum. Hypertens. 2006, 20(8):581-586.
17. Virmani R., Burke A.P., Farb A. Sudden cardiac death. Cardiovasc. Pathol. 2001, 10(6):275-282.
18. Reuterwall C., Hallqvist J., Ahlbom A., De Faire U., Diderichsen F., Hogstedt C., et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J. Intern. Med. 1999, 246(2):161-174.
19. Quintana H.K., Vikstrom M., Andersson T., Hallqvist J., Leander K. Agreement between myocardial infarction patients and their spouses on reporting of data on 82 cardiovascular risk exposures. PLoS ONE 2015, 10(7).
20. Beckman J.A., Creager M.A., Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J. Am. Med. Assoc. 2002, 287(19):2570-2581.
21. Aronson D., Rayfield E.J., Chesebro J.H. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann. Intern. Med. 1997, 126(4):296-306.
22. Gronros J., Jung C., Lundberg J.O., Cerrato R., Ostenson C.G., Pernow J. Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 2011, 300(4):H1174-H1181.
23. DeLuca A.J., Kaplan S., Aronow W.S., Sandhu R., Butt A., Akoybyan A., et al. Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus. Am. J. Cardiol. 2006, 98(8):1045-1046.
24. Gurm H.S., Brennan D.M., Booth J., Tcheng J.E., Lincoff A.M., Topol E.J. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am. J. Cardiol. 2002, 90(1):42-45.
25. Wang L., Liu W., He X., Chen Y., Lu J., Liu K., et al. Association of overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of prospective studies. Int. J. Obes. 2016, 40(2):220-228.
26. Lavie C.J., De Schutter A., Milani R.V. Healthy obese versus unhealthy lean: the obesity paradox. Nat. Rev. Endocrinol. 2015, 11(1):55-62.
27. Lavie C.J., McAuley P.A., Church T.S., Milani R.V., Blair S.N. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J. Am. Coll. Cardiol. 2014, 63(14):1345-1354.
28. Lim G.B. Risk factors: CVD risk and the 'obesity paradox'. Nat. Rev. Cardiol. 2015, 12(10):560.
29. Wells J.C. The evolution of human fatness and susceptibility to obesity: an ethological approach. Biol. Rev. Camb. Philos. Soc. 2006, 81(2):183-205.
30. Connor Gorber S., Tremblay M., Moher D., Gorber B. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes. Rev. 2007, 8(4):307-326.
31. Rosendorff C., Black H.R., Cannon C.P., Gersh B.J., Gore J., Izzo J.L., et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation 2007, 115(21):2761-2788.
32. Chang W.C., Boersma E., Granger C.B., Harrington R.A., Califf R.M., Simoons M.L., et al. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am. Heart J. 2004, 148(1):62-71.
33. Abrignani M.G., Dominguez L.J., Biondo G., Di Girolamo A., Novo G., Barbagallo M., et al. In-hospital complications of acute myocardial infarction in hypertensive subjects. Am. J. Hypertens. 2005, 18(2 Pt 1):165-170.
34. Lajous M., Banack H.R., Kaufman J.S., Hernan M.A. Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am. J. Med. 2015, 128(4):334-336.
35. Cepeda-Valery B., Chaudhry K., Slipczuk L., Pressman G.S., Figueredo V.M., Lavie C.J., et al. Association between obesity and severity of coronary artery disease at the time of acute myocardial infarction: another piece of the puzzle in the "obesity paradox". Int. J. Cardiol. 2014, 176(1):247-249.
36. White H., Thygesen K., Alpert J.S., Jaffe A. Universal MI definition update for cardiovascular disease. Curr. Cardiol. Rep. 2014, 16(6):492.
37. Nedkoff L., Knuiman M., Hung J., Briffa T.G. Improving 30-day case fatality after incident myocardial infarction in people with diabetes between 1998 and 2010. Heart 2015, 101(16):1318-1324.